Caicedo et al. [35] studied TNF-α in 35 patients with CLTI and found increased levels (≥8.1) in 68.6% of patients and concluded that this marker is very important in the progression of ischemia, especially in diabetic patients. The gene discussed is TNF; the disease is ischemia.